UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Cuts Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• UBS AM reduced its stake in UnitedHealth Group by 13.4%, now owning approximately 7.44 million shares worth $3.9 billion, making it the 13th largest position in their portfolio.
• Analyst ratings for UnitedHealth have varied, with price targets adjusted by firms such as Oppenheimer and Barclays, contributing to a consensus rating of Moderate Buy and an average target price of $354.86.
• UnitedHealth recently declared a quarterly dividend of $2.21 per share, providing an annual yield of 2.8%, with a payout ratio of 38.30%.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,442,651 shares of the healthcare conglomerate's stock after selling 1,150,067 shares during the period. UnitedHealth Group makes up about 1.0% of UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC's portfolio, making the stock its 13th biggest position. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned approximately 0.82% of UnitedHealth Group worth $3,898,088,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently bought and sold shares of the company. Citizens National Bank Trust Department lifted its stake in UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after acquiring an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH boosted its holdings in shares of UnitedHealth Group by 0.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after acquiring an additional 1,465 shares during the last quarter. Caitlin John LLC boosted its holdings in shares of UnitedHealth Group by 14.8% in the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after acquiring an additional 111 shares during the last quarter. Sherbrooke Park Advisers LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $515,000. Finally, Silvercrest Asset Management Group LLC lifted its stake in shares of UnitedHealth Group by 47.8% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock valued at $19,625,000 after purchasing an additional 12,550 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

UNH has been the subject of a number of research analyst reports. Oppenheimer reduced their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Robert W. Baird restated an "underperform" rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Royal Bank Of Canada reduced their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Sanford C. Bernstein increased their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a research note on Friday. Finally, Barclays raised their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research note on Thursday, September 4th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average target price of $354.86.

UnitedHealth Group Stock Up 1.6%

Shares of UnitedHealth Group stock opened at $320.46 on Tuesday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a 50 day moving average of $288.96 and a 200 day moving average of $371.54. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $290.24 billion, a P/E ratio of 13.88, a P/E/G ratio of 2.04 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the business posted $6.80 EPS. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.8%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.